The Delhi High Court today sought response from Delhi government in a plea seeking a direction to cap the price of the High-Resolution Computerised Tomography (HRCT) test undertaken by patients having COVID-19 symptoms (Shivleen Pasricha bs GNCTD).
A Division Bench of Chief Justice DN Patel and Justice Jasmeet Singh issued notice in the public interest litigation preferred by advocate Shivleen Pasricha.
The petitioner highlighted that HRCT is now a highly recommended test to determine the presence and severity of COVID-19 infection in the lungs of those who are unwell.
Since the cost of HRCT in the national capital is unregulated, it is the petitioner’s case that the test is currently “beyond the affordability of a common man”.
“At present, the price for getting HRCT done in Delhi is somewhere between INR 5000 to INR 6500. As such, regulation of price of the same has become the need of an hour,” the petitioner stated.
As per the Petitioner, right to heath is a fundamental right guaranteed under Article 21 of the Constitution of India, 1950, and the same includes right to affordable treatment.
As was done for RT-PCR test for COVID-19, the price for HRCT should also be capped by the authorities, the petitioner prayed.
“The need of the hour is to take immediate steps by the Respondents to make HRCT, an essential test for COVID-19, available to the common man, at reasonable and affordable prices,” it was argued.
It was also submitted that several States like Madhya Pradesh, Punjab and Andhra Pradesh have already capped the price of HRCT.
The PIL was filed through advocate Amresh Anand.